{
  "document_id": 51,
  "timestamp": "2025-10-09T01:11:47.258567",
  "stage": "pdf_extraction",
  "text_length": 18872,
  "text_content": "--- Page 1 (OCR) ---\nathena 09/26/2024 11:42 AM ET 515-88344830 pq 1 of 12\nMARK M MEDEIROS MD _« 10210 N. 92ND ST STE 305, SCOTTSDALE AZ 85258-4525\n\nSIMS, Mike J (Legal name: Michael Sims) | (id #1042, dob: 08/03/1952)\n\nMedical Records - CONFIDENTIAL\n\nFROM: AZ - Medeiros, Mark\n\nLorena R\n\n10210 N. 92ND ST STE 305, SCOTTSDALE, AZ 85258-4525\nPhone: (480) 551-6979\n\nFax: (480) 551-9725\n\nTO:\n\nName: SIMS, MICHAEL J\nDOB: 08/03/1952\nDate Range: 01/01/2022 to 09/26/2024\n\nThis document contains the following records of the patient:\ne Lab Results\n\nThis fax may contain sensitive and confidential personal health information that is\nbeing sent for the sole use of the intended recipient. Unintended recipients are\ndirected to securely destroy any materials received. You are hereby notified that the\nunauthorized disclosure or other unlawful use of this fax or any personal health\ninformation is prohibited. To the extent patient information contained in this fax is\nsubject to 42 CFR Part 2, this regulation prohibits unauthorized disclosure of these\nrecords. If you received this faxin error, please visit www.athenahealth.com/Not My Fax to\nnotify the sender and confirm that the information will be destroyed. If you do not\nhave internet access, please call 1/888/482-8436 to notify the sender and confirm\nthat the information will be destroyed. Thank you for your attention and cooperation.\n[ID:1042-A-17798]\n\n--- Page 2 (OCR) ---\nathena 09/26/2024 11:42 AM ET 515-88344830 pq 2 of 12\nMARK M MEDEIROS MD _« 10210 N. 92ND ST STE 305, SCOTTSDALE AZ 85258-4525\n\nSIMS, Mike J (Legal name: Michael Sims) | (id #1042, dob: 08/03/1952)\n\nLab Results\n\nGRIP TEST* 08/23/2024 (#168971, 08/23/2024 11:23am)\n\n78 Ibs. 80 Ibs. Dominant\n\nASSN EEE\n\nPescccrrcrsherccccces\n\nam)\n\nPHHIHHH AHHH HHH HHH HHH HHH HHA MH HH HH HHH HH HHH MHHAMHAPHPHP HH HHH HAHAHA HHH HAA AA HA AA A AA AA A A A A SSS SSS\n: 7 s\n\n: Time taken to walk 4 } 3.31 ; ; ; : ;\n\n: ;\n\n? meters ; 3 ; ; ; ;\n\n3 3 3 3 3 3 3\n\nSerene en ene enn enn een nnn nnn nnn nett nnn nt tne tt tt tt ntti nna natant neni enna nna na nanand senna nana nananinnnnnnnnd\n? iy 3 3 iy 3 3 >\n: Gait speed in meters/s : 1.2 3 ; ; ; ;\n\n: ; ; ; ; ; ;\n\nSSCS SESS SSE SES SESE SESE SSS SESDSSESEOSOSEORG SY ST Saas Soa Saas A Sass\n\nBODY COMPOSITION ANALYSIS (PROC) 08/23/2024 (#168967, 08/23/2024\n11:22am)\n\n2, t 3 N :\n? Right Eye : 20/35 W- Glasses 3 : :\n: Corrected : 3 ; :\n; Ny My 3 :\nPeseceneeeneeneneensnes : SRR nn Senn Seen e tee S rt Serene Step et Set Senter Seer et eet ert tet tet er teeter tere errerns 3 4 :\n: Left Eye : 20/30 ; : : ;\n: N 4 : : :\n; Corrected : } : :\neasssnsnsensnannenanandensnaensnanneanaensnansenanaenanaanenonaenanaanenonaanenaanensnaanenaanensnaanenaaaenanaenenaagensaaanenaayy Sassen Sree Sassesnansanaansangensenanaanas 5S\nColor Vision : normal ; ; : :\nes ee EEEEEEE_____L__ es\nDistance : Good : 3 ;\n\n? Vision : : ; :\nSe Se ROSS SSSOSESOSOSOSSSSOROSOSOSOOSSSSOSOSOSOSOSSSSOSOSOSOSCSSSSOSOSOSOSOSOSCSSOSOSOSOSOSSSSOSOSO SONOS SS SOSOSOSOSOSSSSOSOSORONSS 4 asssesesessstananadinesnaens 3\n: : : \\ ;\n? Near Vision : Fair : : ;\n3 3 3 H\n\nSeerererrererererettrertrttrtttttcertcettttttttttttttttttttttctttttcettetttttttttttttttttttttttttttttttt Stttttttttertctttttttttttttt Sctcrrrrrtrrrnn Nasaseee Saaseaessaeasasasandaaaasaaaaeas 2\n\nMichael wears glasses with progressive lense/bifocal lens- unable to complete near vision exam due to progressive\nlense.\n\n--- Page 3 (OCR) ---\nathena 09/26/2024 11:42 AM ET 515-88344830 pa 3 of 12\nMARK M MEDEIROS MD _« 10210 N. 92ND ST STE 305, SCOTTSDALE AZ 85258-4525\n\nSIMS, Mike J (Legal name: Michael Sims) | (id #1042, dob: 08/03/1952)\n\nLIPOPROTEIN FRACTIONATION, NMR W/ LIPID PANEL W/ TG/HDL-C\n08/28/2024 (#169313, Final, 08/23/2024 9:30am)\n\n§ CLEVELAND HEARTLAB - MANUAL ORDER ONLY\n701 CARNEGIE AVE\n\nMARK M. MEDEIROS, MD\n\nC 2372401830\n\n08/23/2024 09:30\n\n08/24/2024 16:09\n\n08/27/2024 10:43\n\n--- Page 4 (OCR) ---\nathena 09/26/2024 11:42 AM ET 515-88344830 pa 4 of 12\nMARK M MEDEIROS MD _« 10210 N. 92ND ST STE 305, SCOTTSDALE AZ 85258-4525\n\nSIMS, Mike J (Legal name: Michael Sims) | (id #1042, dob: 08/03/1952)\n\nRelative risk: Optimal <935; Moderate 935-1816; High >1816 nmol/L. Reference range is\n592-2404 nmol/L. This test was developed and its analytical performance characteristics\nhave been determined by Quest Diagnostics Cardiometabolic Center of Excellence at\nCleveland Heart Lab. It has not been cleared or approved by the U. S. Food and Drug\nAdministration. This assay has been validated pursuant to the CLIA regulations and is used\nfor clinical purposes. Relative risk:\nnmol/L.\n\n: Relative risk: Optimal >20.5; High <20.6 nm. Reference range is 20.0-22.3 nm.\ni sosntennenennennenennnnegpennennnnenennnnent su nsennentnnenennnnenennenennnn sgeveeneneneenenennnenen seneennenenennenen sesseneneeneneennenen genes\nHDL-P 39.1 i >32.8 : UMOL/L : Final ;\n: Relative risk: Optimal >32.8; Moderate 29.2-32.8; High <29.2 umol/L. Reference range is\n: 21.1-43.4 umol/L.\n§ cscueessssesunsueeneee A cccccnseusneeeenee evonsnuansnuansntnyansnnaninuanananan cecceuseeuenseeen\n‘LARGEHDL-P i >7.2\n: Relative risk: Optimal >7.2; Moderate 5.3-7.2; High <5.3 umol/L. Reference range is >3.5\n! umol/L\n: HDL SIZE : 8.5 : >9.0 :NM > LOW Final : CHL\n! Relative risk: Optimal >9.0; Moderate 8.7-9.0; High <8.7 nm. Reference range is 8.3-10.5\ni nm.\n: LARGE VLDL-P {2.4 : <3.7 : NMOL/L : Final CHL\n\nRelative risk: Optimal <3.7; Moderate 3.7-6.1; High >6.1 nmol/L. Reference range is <16.0\nnmol/L.\n\nelative risk: Optimal <47.1; Moderate 47.1-49.0; High >49.0 nm. Reference range is 41.1-\n1.7 nm.\n\nnw\n\n--- Page 5 (OCR) ---\nathena 09/26/2024 11:42 AM ET 515-88344830 pa 5 of 12\nMARK M MEDEIROS MD _« 10210 N. 92ND ST STE 305, SCOTTSDALE AZ 85258-4525\n\nSIMS, Mike J (Legal name: Michael Sims) | (id #1042, dob: 08/03/1952)\n\nVITAMIN D 25 HYDROXY LC-MS/MS 08/28/2024 (#169312, Final, 08/23/2024\n9:30am)\n\nMARK M. MEDEIROS, MD CLEVELAND HEARTLAB - MANUAL ORDER ONLY\n6701 CARNEGIE AVE\n\nSTE 500\n\nCLEVELAND OH 44103\n\nC 2372401830 EDTAPO\n\n08/23/2024 09:30\n\n08/24/2024 16:09\n\n08/27/2024 23:27\n\nz\n\nfeereerere ty\n\nVitamin D, 25-Hydroxy reports concentrations of two common forms, 25-OHD2 and 25-OHD3. 25-OHD3\nindicates both endogenous production and supplementation. 25-OHD2 is an indicator of exogenous\nsources, such as diet or supplementation. Therapy is based on measurement of Total 25-OHD, with\nlevels <20 ng/m L indicative of Vitamin D deficiency, while levels between 20 ng/m L and 30 ng/m L\nsuggest insufficiency. Optimal levels are >=30 ng/m L. For additional information, please refer to}\nhttp: //education.questdiagnostics.com/faq/FAQ199(This link is being provided for :\ninformation/educational purposes only.)This test was developed and its analytical performance\ncharacteristics have been determined by Quest Diagnostics Cardiometabolic Center of Excellence ati\nCleveland Heart Lab. It has not been cleared or approved by the U. S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. }\n\n--- Page 6 (OCR) ---\nathena 09/26/2024 11:42 AM ET 515-88344830 pa 6 of 12\nMARK M MEDEIROS MD _« 10210 N. 92ND ST STE 305, SCOTTSDALE AZ 85258-4525\n\nSIMS, Mike J (Legal name: Michael Sims) | (id #1042, dob: 08/03/1952)\n\nMYELOPEROXIDASE (MPO) 08/28/2024 (#169311, Final, 08/23/2024 9:30am)\n\nCLEVELAND HEARTLAB - MANUAL ORDER ONLY\n6701 CARNEGIE AVE\n\nSTE 500\n\nCLEVELAND OH 44103\n\nMARK M. MEDEIROS, MD\n\nEDTAPO\n\n08/28/2024 00:06\n\nt\n\nFinal CHL\n\neececece dy\n\n: MYELOPEROXIDASE : 304 : <470 : PMOL/L\n\ni : i :\nBanner ene eee ee RT EEE Sena enna enna nnnaaannaannasantaaennaa thas enna ennasennasennasannaaannatanssannsnnnsannanannnnad\n\n: Based on a high risk sub-population (N=920) defined as ambulatory stable patients\n\nwithout acute coronary syndrome who underwent elective diagnostic coronary angiography\n\n: (1) and a reference range study of apparently healthy donors, we have defined the\n\n{ following cut-offs for MPO: A cut-off of <470 pmol/L defines an ‘apparently healthy' :\n: population at optimal relative risk for a cardiovascular event, 470-539 pmol/L defines ai\npopulation at moderate relative risk for a cardiovascular event (2-fold increased risk\n\n! of MACE at 3 years), and > = 540 pmol/L defines a population with a high relative risk\n\n{ for a cardiovascular event. (Reference: 1. Tang et al. Am J Cardiol. 2013; 111:465-470\nand personal communication with Tang et al). This test was developed and its analytical\n\n: performance characteristics have been determined by Quest Diagnostics Cardiometabolic\n{Center of Excellence at Cleveland Heart Lab. It has not been cleared or approved by the\n\ni U. S. Food and Drug Administration. This assay has been validated pursuant to the CLIA\n\n: regulations and is used for clinical purposes.\n\nocc ccc ccc coccccecennes OEE eee Cert rete etre teen een eete eee eten rn teen tet eett reer tre tt teen tet teeter ttte tn tern tet terete terete tert tee erereererer ent ern eter eeeree recente ere eeenneet ey\n\n: RESULT NOTE i\n‘ FASTING: 0.0 HOURS\n\nDanneel?\n\n--- Page 7 (OCR) ---\nathena 09/26/2024 11:42 AM ET 515-88344830 pa 7 of 12\nMARK M MEDEIROS MD _« 10210 N. 92ND ST STE 305, SCOTTSDALE AZ 85258-4525\n\nSIMS, Mike J (Legal name: Michael Sims) | (id #1042, dob: 08/03/1952)\n\nLIPID PANEL W/ TG/HDL-C 08/28/2024 (#1693\n\nMARK M. MEDEIROS, MD\n\n|, 08/23/2024\n\nCLEVELAND HEARTLAB - MANUAL ORDER ONLY\n6701 CARNEGIE AVE\n\nSTE 500\n\nCLEVELAND OH 44103\n\nC 2372401830 SERUM RPO\n08/23/2024 09:30\n08/24/2024 16:09\n\n08/27/2024 13:10\n\n: CHOLESTEROL, : 129 : | MG/DL : ! CHLHARVEST\n\n! HDL | >39 \\ MG/DL : Final ‘ CHLHARVEST\n\n: CHOLESTEROL :\n\nn S Coenen een nnn Fa ne fn\n: CHLHARVEST\n\nE CHOLESTEROL i sssnsnsnsnnnninnnmnentinnnnnnnnnnnnn innnninnnnnnnnnnnannnnnnnnne nennanannnahaimannennnnan aaannnnnnnnnnnnnannnannnnnn\n\n{Desirable range <100 mg/d L for primary prevention; <70 mg/d L for patients with CHD or\n\ni diabetic patients with >= 2 CHD risk factors.\n\n! LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel\n{method providing better accuracy than the Friedewald equation in the estimation of LDL-C.\n‘Martin SS et al. JAMA. 2013;310(19): 2061-2068\n\n: (http: //education . Quest Diagnostics.com/faq/FAQ164)\n\nFenner NS EE ENED\n> 3 3 yi : N\n\n: CHOL/HDL-C ‘ <5.0 ‘CALC : Final : CHLHARVEST\n: NON-HDL ‘ <130 ‘ MG/DL (CALC) : : Final ! CHLHARVEST\nE CHOLESTEROL ovccecceecced Lccccccececceeeeccceeencceeenccees Xcccecceuccceeuceeeencceeenecceencceenncneed Scccccucceeeecceeediccceeuccceeucceeeeees Sascensaceennncsennnnsenninnneninneeniannenns i\n: ! For patients with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of :\n\n£<100 mg/d L (LDL-C of <70 mg/d L) is considered a therapeutic option. ECC Ree e R ee tree etree etree ener eereeenneet prentensenseneeensageaneaneanennantansaneaneaneanansansaneuneanannansansaneaneanannantand\n\n‘HIGH [Final ‘ CHLHARVEST\n\noer ee rece ee tee teeteetentenel eetetttctcntententer tecttttectentertententtrtctenttn enterterterttttrtentrtentertetterettttterttctenterterterttttrttctertentereerecrertcnn, coc ccc ccccccrry\n\n! RESULT NOTE\n\na\nN\n°\n5\nom\no O\n\nASTING: 06.0 HOURS\n\n--- Page 8 (OCR) ---\nathena 09/26/2024 11:42 AM ET 515-88344830 pa 8 of 12\nMARK M MEDEIROS MD _« 10210 N. 92ND ST STE 305, SCOTTSDALE AZ 85258-4525\n\nSIMS, Mike J (Legal name: Michael Sims) | (id #1042, dob: 08/03/1952)\n\nHEMOGLOBIN ALC 08/28/2024 (#169309, Final, 08/23/2024 9:30am) _\n\nMARK M. MEDEIROS, MD CLEVELAND HEARTLAB - MANUAL ORDER ONLY\n6701 CARNEGIE AVE\nSTE 500\n\nCLEVELAND OH 44103\n\n08/26/2024 20:55\n\n: HBAIC : 5.8 : <5.7 1% : HIGH Final i CHLHARVEST\n\nRenner nnnnnnnnnnennnt Ginnnnnn Tnnnennentet tenn n TTTTEEEnn Canennnnnnntettttnnnnnntt Cntnnnnnnnnt Tnnnnnnnt Set ttetntnn Tn Tn Ennnnnnnn Seneanneeneee tet tnnnnnn Te Tenn nnn nnn ne Tnnettttt\n\ni For someone without known diabetes, a hemoglobin Alc value between 5.7% and 6.4% is consistent\niwith prediabetes and should be confirmed with a follow-up test. For someone with known\n\n? diabetes, a value <7% indicates that their diabetes is well controlled. Alc targets should be\n} individualized based on duration of diabetes, age, co-morbid conditions and other\n\ni considerations. This assay result is consistent with an increased risk of diabetes.\n\n} Currently, no consensus exists regarding use of hemoglobin Alc for diagnosis of diabetes in\n\n} children. This test was performed on the Roche cobas c503 platform. Effective 3/5/2024, a change in test\n} platforms from the Abbott Architect to the Roche cobas c503 may have shifted Hb Alc results\n\n? compared to historical results. Based on laboratory validation testing conducted at Quest, the\n: Roche platform relative to the Abbott platform had an average increase in Hb Alc value of\n\n} <=0.3%.\n\n: This difference is within accepted variability established by the National Glycohemoglobin\n\n} Standardization Program. Note that not all individuals will have had a shift in their results\nt and direct comparisons between historical and current results for testing conducted on\n\n} different platforms is not recommended.\n\n: ESTIMATED :\n: AVERAGE\n: GLUCOSE\n\nRESULT :\nNOTE : FASTING: 06.0 HOURS\n\n--- Page 9 (OCR) ---\nathena 09/26/2024 11:42 AM ET 515-88344830 pa 9 of 12\nMARK M MEDEIROS MD _« 10210 N. 92ND ST STE 305, SCOTTSDALE AZ 85258-4525\n\nSIMS, Mike J (Legal name: Michael Sims) | (id #1042, dob: 08/03/1952)\n\nTHYROID STIMULATING HORMONE 08/28/2024 (#169308, Final, 08/23/2024\n9:30a\n\nSSA RR DADRA RRR RRA RRR RRA RAR RA RANA RRA R ARR ARR RR RRA RRA RRR IIT\n4\n\nS\n$\n\nMARK M. MEDEIROS, MD $ CLEVELAND HEARTLAB - MANUAL ORDER ONLY\n$ 6701 CARNEGIE AVE\n{ STE 500\nCLEVELAND OH 44103\n\nPOOLE LLLELEEEEEE\n\n: THYROID £1.31\n: STIMULATING\n\n: HORMONE ; :\n} (TSH) ? For additional information, please refer to http://education. Quest Diagnostics .com/ faq/FAQ138 :\n\ni This test was performed using the Siemens TSH immunoassay method. Values obtained with\niprevious assay methods cannot be used interchangeably.\n\n}RESULTNOTE :\n: FASTING: 0.0 HOURS\n\nDiana ERE EER ARERR ERE ERE RARER BARE RAR ERLR ARERR ERA REREAR ELAR ERA RE ER AR ERA EERE ARERR RELA REEL EERE RERRARERERERERD\n\n--- Page 10 (OCR) ---\nathena 09/26/2024 11:42 AM ET 515-88344830 pq 10 of 12\nMARK M MEDEIROS MD _« 10210 N. 92ND ST STE 305, SCOTTSDALE AZ 85258-4525\n\nSIMS, Mike J (Legal name: Michael Sims) | (id #1042, dob: 08/03/1952)\n\nCOMPREHENSIVE METABOLIC PANEL 08/28/2024 (#169307, Final, 08/23/2024\n9:30am)\n\nCLEVELAND HEARTLAB - MANUAL ORDER ONLY\n6701 CARNEGIE AVE\n\nSTE 500\n\nCLEVELAND OH 44103\n\nMARK M. MEDEIROS, MD\n\n--- Page 11 (OCR) ---\nathena\n\n09/26/2024 11:42 AM ET 515-88344830\n\nMARK M MEDEIROS MD _« 10210 N. 92ND ST STE 305, SCOTTSDALE AZ 85258-4525\n\npq 11 of 12\n\nSIMS, Mike J (Legal name: Michael Sims) | (id #1042, dob: 08/03/1952)\n\n: CALCIUM\n\n: SODIUM\n: POTASSIUM\n: CHLORIDE :\n\n: CO2 (CARBON :\n: DIOXIDE) :\n\n} PROTEIN, TOTAL\n\n9.9\n\nTenens seen teeta tena nanan anna\n\n: ALBUMIN 4.2\n! GLOBULIN 2.2\n! ALBUMIN/GLOBULIN { 1.9\n\n: 26\n\n! ALANINE\n: AMINOTRANSFERASE |\ncan :\n\nennenr tne ene ten ntneenter een reeeecnenes Orn en Ener een er eer n tent eee ere eeceenrennt\n\n; wcbececceeeneeneeenes Rca :\n‘ 8.5-10.5 : MG/DL {Final = CHL\n\nAne,\n\n136-145 : MMOL/L i | Final SCHL\n\n3\n3\n3\n3\n3\n3\n3\n3\n3\n3\n3\n3\n3\n3\n3\n3\n3\n3\n3\n3\n3\n3\n3\n3\n3\n3\n3\nj\npoder\n3\n3\n3\n\nWw\na\nuw\nHn\n\nMMOL/L i | Final\n\nte)\ny\nnn\n2\n©\n\nMMOL/L fi Final = S CHL\n\nN\nr\nw\nw\n\n: MMOL/L {Final = S CHL\n\n0.70-1.28 | MG/DL St Final\n\naaa EET aa a S SEIT T SNE TS TESS ST ITTY SYSETTS TTS SSIS CSS SETTTTTSSS STL ISSTEET TTS TTTTT TS TESTE TTS\n\npecccseees\n\n:\n:\n:\n:\n:\nperrdprererenreresierrereererees\n:\n:\n:\n:\n:\n:\n:\n:\n:\n\neeccecsesecetetdpeteeee settee bet\n\n' ASPARTATE ‘22\n\n: AMINOTRANSFERASE | :\n\n: BILIRUBIN, TOTAL =: 0.3 ‘<13 { MG/DL i Final = {CHL\n\n! BUN/CREATININE | NOTAPPLICABLE | 6-22 ‘ CALC {i Final = S CHL\n\n: RATIO _\n\ni sosossuannnensuaassensuaasnensuasseauuananennuuaaneenuaaneenaunsaseneesss \\ scsssussseuesseuenenes J esesesseneeneeneeeseeneeneeneenteeneenenn BE cccseasee eneerenre\nEGFR 91 \\ >59 : ML/MIN/1.73M SQUARED i | Final CHL\n\ny\nt\n\nBeare ene eee een tin ean n nantes enh IR HR SRI SA ER RI I EL ES ng LU A Uneaten ean dinanaannnnnnnnal\n\n: The e GFR is based on the CKD-EPI 2021 equation. To calculate the new e GFR from a\n: previous Creatinine or Cystatin C result, go to\n‘ https ://www.kidney.org/professionals/kdogi/gfr¢5Fcalculator.\n\ni\n\nLaassseesssneesssnnseessananvssaaaeneaaa Savuneeessnneessnnnanssuanenessanaayssannaeusaauayesaanaaesaannaysaanaessaaaayeaaanaayssaaaayssaaaaessaaaayeaaaaaaysaaaaaessaaaaessaagayeaaaaaaysaaaaessaaaayesaaaaaesaaaaayeaa 3\n: 4\n:\n\n: RESULT NOTE\n\nFASTING: 06.0 HOURS\n\nDaannnnnn nen cc ccc ccc cc ccc cc cc cc ccc ccc ccc cccc\n\n--- Page 12 (OCR) ---\nathena 09/26/2024 11:42 AM ET 515-88344830 pq 12 of 12\nMARK M MEDEIROS MD _« 10210 N. 92ND ST STE 305, SCOTTSDALE AZ 85258-4525\n\nSIMS, Mike J (Legal name: Michael Sims) | (id #1042, dob: 08/03/1952)\n\nCBC WITH DIFFERENTIAL 08/28/2024 (#169306, Final, 08/23/2024\n\nMARK M. MEDEIROS, MD\n\nam)\n\nCLEVELAND HEARTLAB - MANUAL ORDER ONLY\n6701 CARNEGIE AVE\n\nSTE 500\n\nCLEVELAND OH 44103\n\nC 2372401830\n08/23/2024 09:30\n08/24/2024 16:09\n\n08/24/2024 23:41\n\nee ‘\n: i ———\ndcaceccecceeceecuceuceeeeseecuecuseuseesesecuseuseusnesecuceuceuseeceececeuceuceeseeseeee f eevenmeecenmececenece Seeececececeeneceecnececenecerent cueeneceecneecceet emnten Gneeteceecceceeceecentt Seneeteeneeteentt\n: : 80.0-100.0 FL | Final i CHL\n27.0-33.0 PG a ‘ :\nMCHC : 33.4 | 32.0-36.0 :G/DL ‘ :\n' RED CELL DISTRIBUTION WIDTH 13.8 :11.0-15.0 i% \\ : :\n| PLATELET COUNT ‘ 261 : 140-400 PKUL\n: e ERRRRRTeenn EEEEr EEneer TT TTnnnneerenneen TT Tennnnnerereenr tr c Tnnnrerrreeeer Tre Tereceeereentt Seveescenecenncennceuabccnsucnsuensncneneseueneneseuaseatecaseenseeaseensen ovesees ‘ 4 :\n: MEAN PLATELET VOLUME ; | Final CHL\n: NEUTROPHIL % i 38,0-80.0 | Final SCHL\nBessette ceeneeceeneen Soe ene Sommnnfrmnnnnnnnnnns Sonny :\n{ NEUTROPHIL ABSOLUTE ‘3.19 : 1,50-7.80 PKUL =} Final SCHL i\n: LYMPHOCYTE % {24.1 : 15.0-49.0 :% {Final -CHL\n{osssensannnnnnnnnnnnnnsnnnnnnnannnnnnnsnannennsnnanennanannnnanannnnansannn Sevsscssnnnnnnnnnn Sevssssssnnnnnnsannnnnnnnnnnns Sevssnssnnnnnnny Sane ED Spessecsnnnnnse :\n: LYMPHOCYTE ABSOLUTE 1.21 } 0.85-3.90 : KUL / {Final SCHL\nSscececucesusneetecesusanetetecussnanetetatususnsnatatacususnananeteueusususneneeueanse i eevenmeeceeneerenee E Seeneceneeeneceenceeenecennceeen Eeceneceneceeneeeen Banneedacnnrnscnnensnnnens ecemeeeneeentes ;\n: MONOCYTE % | Final SCHL\n: MONOCYTE ABSOLUTE : 0.20-0.95 KUL | Final ‘CHL\nSense Se EEE! aan Dae eel\n: EOSINOPHIL % : 2.8 : 0.0-8.0 1% ‘ Final © CHL\n\n: EOSINOPHIL ABSOLUTE 0.14 } 0.00-0.50 2 KUL\n\no Cet ect eeeee treet teertctertteetttettttentttrrttettcetrttectttenttenrttetetttttterttttrnttnnctertterrttertceeccess Oreerteeetttertteertternttertttentterrrerttennreenns\nrn > +\n\nBASOPHIL ABSOLUTE\n\n: RESULT NOTE\n\nCHL\n\nnee ee\n\na\n=\no\n\neecccccetpeccereeepeentee eee\n\n5\no\nTOOTS INIT SUT TT INIT TUTTI INE:\nia)\nx\nr T",
  "metadata": {
    "page_count": 12,
    "file_size_mb": 0.61,
    "pdf_metadata": {
      "title": "/var/spool/fax/recvq/fax001469742.tif",
      "author": "",
      "creator": "tiff2ps",
      "creation_date": "D:20240926094651-06'00'",
      "extraction_method": "ocr"
    }
  }
}